ERRATUM Targeted antitumoral dehydrocrotonin nanoparticles with L-ascorbic acid 6-stearate. J Pharm Sci 98: 4796–4807. LUCAS FRUNGILLO,1 DORIVAL MARTINS,2,3 SE´RGIO TEIXEIRA,4 MARISTELA CONTI ANAZETTI,1 ´ N3 PATRI´CIA DA SILVA MELO,5 NELSON DURA 1
Laborato´rio de Cultura de Ce´lulas e Biofa´rmacos, Instituto de Biologia, Universidade Estadual de Campinas, UNICAMP, Campinas, SP, Brazil 2
Laborato´rio de Genoˆmica e Biologia Molecular Bacteriana, Instituto de Biologia, Universidade Estadual de Campinas, UNICAMP, Campinas, SP, Brazil
3
Laborato´rio de Quı´mica Biolo´gica, Instituto de Quı´mica, Universidade Estadual de Campinas, UNICAMP, C.P. 6154, Campinas, CEP 13083-970, SP, Brazil 4
Laborato´rio de Quı´mica Inorgaˆnica, Instituto de Quı´mica, Universidade Estadual de Campinas, UNICAMP, Campinas, SP, Brazil
5
Faculdades Integradas Metropolinas de Campinas, METROCAMP, Campinas, SP, Brazil
Published online 14 April 2009 in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jps.21760
The original article to which this erratum refers was published in 2009; 98: 4796–4807. In the original version of this article there is an error in the title of Table 3. That error has been corrected in the table below.
Table 3. Cytotoxicity on HL-60 Cells Treatment Assay IC30 (mM) IC50 (mM) IC70 (mM)
DHC
NP-DHC
NP-AAS-DHC
MTT
TB
MTT
TB
MTT
TB
150 3.3 190 10 350 2.1
75 5.0 140 5.2 230 4.4
90 1.6 200 4.0 300 4.8
30 2.1 110 2.1 NF
35 9.9 140 4.8 350 3.4
40 2.3 90 11 200 5.6
Correspondence to: Nelson Dura´n (Telephone: 55-19-35213149; Fax: 55-19-35213023; E-mail:
[email protected]) Published online 6 January 2010 in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jps.22081 Journal of Pharmaceutical Sciences, Vol. 99, 2529 (2010) ß 2010 Wiley-Liss, Inc. and the American Pharmacists Association JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 99, NO. 5, MAY 2010
2529